Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Itakura, M. Shingyoji, T. Iizasa, Y. Yoshida, H. Ashinuma, Y. Miriya, H. Tamura (Chiba Prefecture, Japan). CCR2, CCR5, their ligands and chemokine receptor-interacting protein FROUNT have impressive effects on pulmonary adenocarcinoma. Eur Respir J 2013; 42: Suppl. 57, 4640

Member's Comments

No comment yet.

Related content which might interest you: CD163 and CCR7 markers for macrophage polarisation in patients with lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Neurotrophin TrkB receptor mediates the epithelial to mesenchymal transition in lung adenocarcinoma cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Expression of interleukin-18 and interleukin-18 receptor mRNA in lung tissue samples from non small lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Macrophages promote urethane-induced lung adenocarcinoma Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 A role for cAMP-responsive element binding protein in lung adenocarcinoma Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 A requirement for IKKa in lung adenocarcinoma Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis Source: Eur Respir J 2009; 34: 676 Year: 2009 Polymorphism of chemokine receptor gene CCR5 in patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 266s Year: 2003 Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013 Year: 2013 Surface vs. intracellular CTLA-4 expression in lung cancer Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Inhibition of human lung H460 cell proliferation by siRNA-mediated macrophage migration inhibitory factor (MIF) blocking Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013